The 2025 2nd China-Europe Scientists Forum & 4th International Symposium on Clinical Medicine and Intelligent Devices (CMID 2025) was successfully held from October 31 to November 2, 2025, in Heidelberg, Germany. The forum brought together leading academics, clinicians, and industry experts from China and various European countries to discuss cutting-edge advances in clinical medicine and the integration of intelligent medical devices.

Prof. Pier Paolo Piccaluga, the editorial board member of Exploration of Targeted Anti-tumor Therapy (ETAT) from the University of Bologna, Italy, attended the forum as Conference Chair and delivered a well-received keynote speech, drawing significant attention from participants.

During the conference, Prof. Piccaluga took the opportunity to introduce ETAT to the international attendees. He highlighted the journal's mission, growing academic influence, and key milestones, noting its indexing in databases such as PubMed, Scopus, CAS, and DOAJ, along with its solid CiteScore performance.

This promotion at CMID 2025 has further raised the international profile and academic reputation of ETAT. The editorial office sincerely appreciates Prof. Piccaluga's ongoing support and looks forward to collaborating with scholars worldwide to advance research in targeted cancer therapy.